Skip to main content

Table 1 Characteristics of participants with spinal cord injury

From: Retraining walking over ground in a powered exoskeleton after spinal cord injury: a prospective cohort study to examine functional gains and neuroplasticity

Participant code-gender

Age range

Neurological level of injury

AIS

Cause of injury

Time since injury (yr)

Anti-spastic medication

P1

2

T3

B

MVA

4.2

Baclofen

P2

1

C7

C

MVA

5.7

Baclofen, Tizanidine, Oxybutynin

P3

1

C6

C

MVA

2.5

Baclofen, Oxybutynin

P4

3

T6

A!

Crush injury

24.2

Baclofen, Diazepam, Oxybutynin

P5

2

T4

A!

Sports

16.2

Oxybutynin

P6

2

T3

A

MVA

4.3

Oxybutynin

P7

1

T7

A

MVA

2.4

Baclofen, Oxybutinin

P8

2

T9

A

Fall

1.3

Oxybutynin

P9

1

T10

B!

MVA

2.0

Baclofen

P10

2

T4â–²

Câ–²

MVA

4.4

Baclofen, Oxybutinin

P11

3

C6

D!

MVA

18.7

Baclofen

P12

1

T7

A!

MVA

1.6

Baclofen

Meana

(SD)

37.5

(13.7)

   

7.6

(8.1)

 
  1. Age ranges are used rather than exact numbers to avoid potential identification of individuals. Age range: 1 = 18–30 yr., 2 = 31–50 yr., 3 = 50–65 yr. The mean and SD for age were calculated from the actual age of each participant. AIS was that obtained in discharge summaries from rehabilitation centers unless otherwise indicated. AIS - ASIA Impairment Scale, T – thoracic, C – cervical, MVA - motor vehicle accident, SD - standard deviation. Symbols: aMean and SD do not include P6 who dropped out after 2 sessions of training. !AIS results not available from records or never performed, so AIS was estimated based on muscle strength scores and sensory perception. ▲ Evaluation occurred prior to occurrence of syrinx. Syrinx was operated on and resolved before participation in this study